Global Nanomedicine Market Size, Share, and COVID-19 Impact Analysis, By Modality (Treatment and Diagnostics), By Application (Drug Delivery, IVD, Implant, & Vaccine), By Indication (Oncology, Infectious, Cardiovascular, & Neurological), By Molecule (Nanoparticle, Nanotube, & Nanodevice), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 - 2032

Industry: Healthcare
RELEASE DATE Jul 2023
REPORT ID SI2275
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis by Modality
      2. Market Attractiveness Analysis by Application
      3. Market Attractiveness Analysis by Indication
      4. Market Attractiveness Analysis by Molecule
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increased prevalence of cancer and chronic illnesses
    3. Restraints
      1. Stringent Regulations
    4. Opportunities
      1. The rise in Government Initiatives
    5. Challenges
      1. 5. Lack of Knowledge
  6. Global Nanomedicine Market Analysis and Projection, By Modality
    1. Segment Overview
    2. Treatment
    3. Diagnostics
  7. Global Nanomedicine Market Analysis and Projection, By Application
    1. Drug Delivery
    2. IVD
    3. Implant
    4. Vaccine
  8. Global Nanomedicine Market Analysis and Projection, By Indication
    1. Oncology
    2. Infectious
    3. Cardiovascular
    4. Neurological
  9. Global Nanomedicine Market Analysis and Projection, By Molecule
    1. Nanoparticle
    2. Nanotube
    3. Nanodevice
  10. Global Nanomedicine Market, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  11. Global Nanomedicine Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Global Nanomedicine Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  12. Company Profiles
  13.  Abbott Laboratories
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  14. COMBIMATRIX CORPORATION
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  15.  Celgene Corporation
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  16. Nanospectra Biosciences, Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  17.  GE Healthcare
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  18. Johnson & Johnson Services, Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  19. Mallinckrodt Pharmaceuticals
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  20. MERCK & CO., INC.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  21.  Pfizer, Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  22.   Teva Pharmaceutical Industries Ltd.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  23.     Arrowhead Pharmaceuticals, Inc
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  24. Recent Developments

  25. SWOT Analysis

    List of Table

  26. Global Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  27. Global Treatment, Nanomedicine Market, By Region, 2022-2032(USD Billion)
  28. Global Diagnostics, Nanomedicine Market, By Region, 2022-2032(USD Billion)
  29. Global Nanomedicine Market, By Application, 2022-2032(USD Billion)
  30. Global Drug Delivery, Nanomedicine Market, By Region, 2022-2032(USD Billion)
  31. Global IVD, Nanomedicine Market, By Region, 2022-2032(USD Billion)
  32. Global Implant, Nanomedicine Market, By Region, 2022-2032(USD Billion)
  33. Global Vaccine, Nanomedicine Market, By Region, 2022-2032(USD Billion)
  34. Global Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  35. Global Oncology, Nanomedicine Market, By Region, 2022-2032(USD Billion)
  36. Global Infectious, Nanomedicine Market, By Region, 2022-2032(USD Billion)
  37. Global Cardiovascular, Nanomedicine Market, By Region, 2022-2032(USD Billion)
  38. Global Neurological, Nanomedicine Market, By Region, 2022-2032(USD Billion)
  39. Global Nanomedicine Market, By Molecule, 2022-2032(USD Billion)
  40. Global Nanoparticle, Nanomedicine Market, By Region, 2022-2032(USD Billion)
  41. Global Nanotube, Nanomedicine Market, By Region, 2022-2032(USD Billion)
  42. Global Nanodevice, Nanomedicine Market, By Region, 2022-2032(USD Billion)
  43. Global Nanomedicine Market, By Region, 2022-2032(USD Billion)
  44. North America Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  45. North America Nanomedicine Market, By Application, 2022-2032(USD Billion)
  46. North America Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  47. North America Nanomedicine Market, By Molecule, 2022-2032(USD Billion)
  48. U.S. Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  49. U.S. Nanomedicine Market, By Application, 2022-2032(USD Billion)
  50. U.S. Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  51. U.S. Nanomedicine Market, By Molecule, 2022-2032(USD Billion)  
  52. Canada Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  53. Canada Nanomedicine Market, By Application, 2022-2032(USD Billion)
  54. Canada Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  55. Canada Nanomedicine Market, By Molecule, 2022-2032(USD Billion)
  56. Mexico Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  57. Mexico Nanomedicine Market, By Application, 2022-2032(USD Billion)
  58. Mexico Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  59. Mexico Nanomedicine Market, By Molecule, 2022-2032(USD Billion)
  60. Europe Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  61. Europe Nanomedicine Market, By Application, 2022-2032(USD Billion)
  62. Europe Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  63. Europe Nanomedicine Market, By Molecule, 2022-2032(USD Billion)
  64. Germany Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  65. Germany Nanomedicine Market, By Application, 2022-2032(USD Billion)
  66. Germany Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  67. Germany Nanomedicine Market, By Molecule, 2022-2032(USD Billion)  
  68. France Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  69. France Nanomedicine Market, By Application, 2022-2032(USD Billion)
  70. France Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  71. France Nanomedicine Market, By Molecule, 2022-2032(USD Billion)
  72. U.K. Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  73. U.K. Nanomedicine Market, By Application, 2022-2032(USD Billion)
  74. U.K. Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  75. U.K. Nanomedicine Market, By Molecule, 2022-2032(USD Billion)
  76. Italy Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  77. Italy Nanomedicine Market, By Application, 2022-2032(USD Billion)
  78. Italy Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  79. Italy Nanomedicine Market, By Molecule, 2022-2032(USD Billion)
  80. Spain Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  81. Spain Nanomedicine Market, By Application, 2022-2032(USD Billion)
  82. Spain Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  83. Spain Nanomedicine Market, By Molecule, 2022-2032(USD Billion)
  84. Asia Pacific Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  85. Asia Pacific Nanomedicine Market, By Application, 2022-2032(USD Billion)
  86. Asia Pacific Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  87. Asia Pacific Nanomedicine Market, By Molecule, 2022-2032(USD Billion)
  88. Japan Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  89. Japan Nanomedicine Market, By Application, 2022-2032(USD Billion)
  90. Japan Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  91. Japan Nanomedicine Market, By Molecule, 2022-2032(USD Billion)
  92. China Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  93. China Nanomedicine Market, By Application, 2022-2032(USD Billion)
  94. China Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  95. China Nanomedicine Market, By Molecule, 2022-2032(USD Billion)  
  96. India Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  97. India Nanomedicine Market, By Application, 2022-2032(USD Billion)
  98. India Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  99. India Nanomedicine Market, By Molecule, 2022-2032(USD Billion)  
  100. South America Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  101. South America Nanomedicine Market, By Application, 2022-2032(USD Billion)
  102. South America Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  103. South America Nanomedicine Market, By Molecule, 2022-2032(USD Billion)
  104. Brazil Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  105. Brazil Nanomedicine Market, By Application, 2022-2032(USD Billion)
  106. Brazil Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  107. Brazil Nanomedicine Market, By Molecule, 2022-2032(USD Billion)
  108. The Middle East and Africa Nanomedicine Market, By Modality, 2022-2032(USD   Billion)
  109. The Middle East and Africa Nanomedicine Market, By Application, 2022-2032(USD Billion)
  110. The Middle East and Africa Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  111. The Middle East and Africa Nanomedicine Market, By Molecule, 2022-2032(USD Billion)
  112. UAE Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  113. UAE Nanomedicine Market, By Application, 2022-2032(USD Billion) 
  114. UAE Nanomedicine Market, By Indication, 2022-2032(USD Billion) 
  115. UAE Nanomedicine Market, By Molecule, 2022-2032(USD Billion) 
  116. South Africa Nanomedicine Market, By Modality, 2022-2032(USD Billion)
  117. South Africa Nanomedicine Market, By Application, 2022-2032(USD Billion)
  118. South Africa Nanomedicine Market, By Indication, 2022-2032(USD Billion)
  119. South Africa Nanomedicine Market, By Molecule, 2022-2032(USD Billion)

List of Figures 

  1. Global Nanomedicine Market Segmentation
  2. Nanomedicine Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Nanomedicine Market
  9. Top Winning Strategies, 2022-2032
  10. Top Winning Strategies, By Development, 2022-2032(%)
  11. Top Winning Strategies, By Company, 2022-2032
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Nanomedicine Market
  20. Nanomedicine Market Segmentation, By Modality
  21.  Nanomedicine Market, For Treatment, By Region, 2022-2032 ($ Billion)
  22. Nanomedicine Market, For Diagnostics, By Region, 2022-2032 ($ Billion)
  23. Nanomedicine Market Segmentation, By Application
  24. Nanomedicine Market, For Drug Delivery, By Region, 2022-2032 ($ Billion)
  25. Nanomedicine Market, For IVD, By Region, 2022-2032 ($ Billion)
  26. Nanomedicine Market, For Implant, By Region, 2022-2032 ($ Billion)
  27. Nanomedicine Market, For Vaccine, By Region, 2022-2032 ($ Billion)
  28. Nanomedicine Market Segmentation, By Indication
  29. Nanomedicine Market, For Oncology, By Region, 2022-2032 ($ Billion)
  30. Nanomedicine Market, For Infectious, By Region, 2022-2032 ($ Billion)
  31. Nanomedicine Market, For Cardiovascular, By Region, 2022-2032 ($ Billion)
  32. Nanomedicine Market, For Neurological, By Region, 2022-2032 ($ Billion)
  33. Nanomedicine Market Segmentation, By Molecule
  34. Nanomedicine Market, For Nanoparticle, By Region, 2022-2032 ($ Billion)
  35. Nanomedicine Market, For Nanotube, By Region, 2022-2032 ($ Billion)
  36. Nanomedicine Market, For Nanodevice, By Region, 2022-2032 ($ Billion)
  37. Abbott Laboratories: Net Sales, 2022-2032 ($ Billion)
  38. Abbott Laboratories: Revenue Share, By Segment, 2022 (%)
  39. Abbott Laboratories: Revenue Share, By Region, 2022 (%)
  40. COMBIMATRIX CORPORATION: Net Sales, 2022-2032 ($ Billion)
  41. COMBIMATRIX CORPORATION: Revenue Share, By Segment, 2022 (%)
  42. COMBIMATRIX CORPORATION: Revenue Share, By Region, 2022 (%)
  43. Celgene Corporation: Net Sales, 2022-2032 ($ Billion)
  44. Celgene Corporation: Revenue Share, By Segment, 2022 (%)
  45. Celgene Corporation: Revenue Share, By Region, 2022 (%)
  46. Nanospectra Biosciences, Inc.: Net Sales, 2022-2032 ($ Billion)
  47. Nanospectra Biosciences, Inc.: Revenue Share, By Segment, 2022 (%)
  48. Nanospectra Biosciences, Inc.: Revenue Share, By Region, 2022 (%)
  49. GE Healthcare: Net Sales, 2022-2032 ($ Billion)
  50. GE Healthcare: Revenue Share, By Segment, 2022 (%)
  51. GE Healthcare: Revenue Share, By Region, 2022 (%)
  52. Gilead Sciences, Inc.: Net Sales, 2022-2032 ($ Billion)
  53. Gilead Sciences, Inc.: Revenue Share, By Segment, 2022 (%)
  54. Gilead Sciences, Inc.: Revenue Share, By Region, 2022 (%)
  55. Johnson & Johnson Services, Inc.: Net Sales, 2022-2032 ($ Billion)
  56. Johnson & Johnson Services, Inc.: Revenue Share, By Segment, 2022 (%)
  57. Johnson & Johnson Services, Inc.: Revenue Share, By Region, 2022 (%)
  58. Mallinckrodt Pharmaceuticals: Net Sales, 2022-2032 ($ Billion)
  59. Mallinckrodt Pharmaceuticals: Revenue Share, By Segment, 2022 (%)
  60. Mallinckrodt Pharmaceuticals: Revenue Share, By Region, 2022 (%)
  61. MERCK & CO., INC.: Net Sales, 2022-2032 ($ Billion)
  62. MERCK & CO., INC.: Revenue Share, By Segment, 2022 (%)
  63. MERCK & CO., INC.: Revenue Share, By Region, 2022 (%)
  64. Pfizer, Inc.: Net Sales, 2022-2032 ($ Billion)
  65. Pfizer, Inc.: Revenue Share, By Segment, 2022 (%)
  66. Pfizer, Inc.: Revenue Share, By Region, 2022 (%)
  67. Teva Pharmaceutical Industries Ltd.: Net Sales, 2022-2032 ($ Billion)
  68. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2022 (%)
  69. Teva Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2022 (%)
  70. Arrowhead Pharmaceuticals, Inc.: Net Sales, 2022-2032 ($ Billion)
  71. Arrowhead Pharmaceuticals, Inc.: Revenue Share, By Segment, 2022 (%)
  72. Arrowhead Pharmaceuticals, Inc.: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2022
Tables & Figures:110
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:12.4%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies